Ayala Pharmaceuticals

AP
AY

Ayala Pharmaceuticals

Clinical-stage oncology company developing small molecule therapeutics for rare tumors and aggressive cancers.

2017ActiveJerusalem, Israel
Rate

About

Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company focused on developing and commercializing novel small molecule therapeutics for patients with rare tumors and aggressive cancers. Their pipeline targets specific genetic alterations that drive tumor growth and resistance to existing therapies.

Signals agent

Reach companies that have budget right now

Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.

  • Just raised a roundFresh budget, the week it lands
  • Hiring sales and marketingGo-to-market roles mean money to spend
  • Hiring fastA jump in open roles across the company
  • In the newsLaunches and announcements worth a message
  • The decision makerWho to contact, with a message you can edit

Is your startup an alternative to Ayala Pharmaceuticals?

People comparing tools land here. Get listed beside these.

Copy Ayala Pharmaceuticals's SEO strategy

How often they publish, which searches their posts chase and their newest posts. Then outrank them.

All funding rounds

Key facts

Website
ayalapharma.com
Headquarters
Jerusalem, Israel
Founded
2017
Founder
Roni Mamluk
Total funding
$72M (Series C)
Business model
B2B

Funding rounds

Funding rounds raised by Ayala Pharmaceuticals
DateRoundAmountLead investors
19 Feb 2021Series C$25M
28 May 2019Series B$30MNovartis Venture Fund
11 Apr 2018Series A$17MIsrael Biotech Fund

Tech stack

Detected on ayalapharma.com, last scanned 7 Nov 2026.

CDN
Cloudflare
Email provider
Microsoft 365

Benchmarking

See how your site ranks against 16,849 startups

Ayala Pharmaceuticals sits in the 37th percentile for Domain Rating. Check where yours lands, free.

Ayala Pharmaceuticals has a Domain Rating of 30, the 37th percentile of 16,849 startups we track.

Scores

Measured, not editorial

30

Measured by AhrefsAhrefs DR

Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.

Below median

Check yours
32

Measured by StartupHub.aiAgent Readiness

How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.

Below median

Scan yours
86

Measured by Google PageSpeedSite Speed

Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.

Top 25%

PageSpeed
63

Measured by StartupHub.aiData Trust

Whether this company is a safe place to put your data: security posture, privacy signals, and reputation evidence we could verify.

Above median

Measured by StartupHub.aiSecurity

What this company’s API or MCP server gives an anonymous stranger: transport, whether anything answers without credentials, CORS, response headers and, when an MCP server replies, which of its tools can be called with no key. Scanned live, on request, because a security verdict months old is worse than none.

Click to scan

Agent Readiness

Can AI agents use your site?

Ayala Pharmaceuticals scores 32. Check yours free in a few seconds, or let Max Agent rerun it daily.

Run it daily with Max Agent
Median 41Across 23,755 scanned sites

Get notified when Ayala Pharmaceuticals changes

Used Ayala Pharmaceuticals? Write a review and get $5 in credits

Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:

  • Email finder
  • Market Map Maker
  • Agent Readiness scans
  • Deep intel
  • Tech stack scans

Frequently asked

Who owns Ayala Pharmaceuticals?

Ayala Pharmaceuticals is privately held, owned by its founders and investors. Israel Biotech Fund has backed 2 of the 3 rounds on record since April 2018, ahead of aMoon (2) and Harel Insurance Investments and Financial Services (2), so it is likely among the largest outside shareholders. Exact stakes are not public.

Are there companies like Ayala Pharmaceuticals?

Yes. We list 6 companies like Ayala Pharmaceuticals, including Somite.ai, Upstream Bio and Mana.bio. Ayala Pharmaceuticals stands out on funding: its $72M is second only to Upstream Bio ($400M) among them.

Is Ayala Pharmaceuticals trustworthy and reputable?

StartupHub's Data Trust & Reputation score for Ayala Pharmaceuticals is 63 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.

How much funding has Ayala Pharmaceuticals raised?

Ayala Pharmaceuticals has raised a total of $72M in funding. The most recent round on record is Series C.

SEC filings, insider activity, nonprofit links and pay benchmarks for Ayala Pharmaceuticals:

Company details: from public sources. Funding: 3 rounds on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules

Categories

Need more than this profile? Deep intel researches any company website: team, funding, customers and tech.

Max Agent

Let Max Agent watch Ayala Pharmaceuticals and its market for you

New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.

Free week

Starter listings, once

AI answers checked

Daily for 7 days

  • ChatGPT
  • Perplexity

Max Agent

$79 a month, or $9.99 with our badge on your site

AI answers checked

Every week

  • ChatGPT
  • Claude
  • Perplexity
  • Gemini